C-Protein in Fatigue and Aging

NCT05926219 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-05-07

No results posted yet for this study

Summary

This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.

Conditions

  • Aging
  • Muscle Atrophy or Weakness
  • Sarcopenia in Elderly
  • Sarcopenia

Interventions

BEHAVIORAL

Fatiguing Exercise

Volunteers will perform knee extension exercise of the dominant limb while seated in a chair designed for exercise of the knee extensor muscle group. The chair will be equipped with a lever arm, aligned with the axis of rotation of the knee and fixed to the distal shank, 2 centimeters proximal to the ankle joint. The lever arm will be instrumented to provide resistance and measure velocity. The volunteers will perform 3-5 maximum voluntary contractions (MVC) to determine peak torque. Once established, volunteers will rest for 5 minutes before initiating the fatigue protocol, whereby they will perform repeated MVC of the dominant limb against resistance equal to or less than 50% of MVC until range of motion cannot be maintained. Because the goal of this exercise is to uniformly fatigue the quadriceps muscle group, this exercise will be performed continuously. It is expected to take between 1 and 3 minutes to achieve the desired level of fatigue.

Sponsors & Collaborators

  • Wu Tsai Human Performance Alliance

    collaborator UNKNOWN
  • National Institutes of Health (NIH)

    collaborator NIH
  • Oregon Health and Science University

    collaborator OTHER
  • Washington State University

    collaborator OTHER
  • National Institute on Aging (NIA)

    collaborator NIH
  • University of Oregon

    lead OTHER

Principal Investigators

  • Damien M Callahan, Ph.D. · University of Oregon

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-06
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05926219 on ClinicalTrials.gov